Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study)-Reference-Cited by-同舟云学术

Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study)

Published:2021-09 Issue:38 Volume:39 Page:5376-5384
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jõgi Piia,Soeorg Hiie,Ingerainen Diana,Soots Mari,Lättekivi Freddy^ORCID,Naaber Paul,Toompere Karolin,Peterson Pärt,Haljasmägi Liis^ORCID,Žusinaite Eva,Vaas Hannes,Pauskar Merit,Shablinskaja Arina,Kaarna Katrin,Paluste Heli,Kisand Kai^ORCID,Oona Marje,Janno Riina,Lutsar Irja

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference31 articles.

1. European Centre for Disease Prevention and Control. COVID-19 data. Weekly data; 2020. https://www.ecdc.europa.eu/en/covid-19/situation-updates-covid-19/covid-19-data/weekly [Cited September 15, 2020].

2. Health Board. Data of Coronavirus SARS-CoV-2 test; 2020. https://www.terviseamet.ee/et/koroonaviirus/avaandmed [cited September 3, 2020].

3. Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020;Havers;JAMA Intern Med,2020

4. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study;Stringhini;Lancet,2020

5. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study;Pollán;Lancet,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia;Journal of Interferon & Cytokine Research;2023-09-01

2. SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study;The Lancet Diabetes & Endocrinology;2023-04

3. RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers;Microbiology Spectrum;2023-02-14

4. Sex and age differences in the proportion of experienced symptoms by SARS-CoV-2 serostatus in a community-based cross-sectional study;Epidemiology and Infection;2022-08-10

5. Clinical characteristics and risk factors for COVID-19 infection and disease severity: A nationwide observational study in Estonia;PLOS ONE;2022-06-16